Literature DB >> 30904882

Percutaneous cryoablation of a solitary, soft-tissue metastasis from renal cell carcinoma: a new local minimal invasive curative treatment.

Theresa Junker1,2, Benjamin Schnack Rasmussen1,3, Anja Toft2, Ole Graumann1,3.   

Abstract

Cryoablation is a well-established treatment option, proven to be successful in treating local renal cell carcinoma (RCC). We treated a 67-year-old man in an outpatient setting with late onset of a 25 mm solitary soft-tissue metastasis of from RCC with cryoablation. The treatment was performed under sedation and in local anaesthesia. There were no complications during the procedure. The patient did not experience any adverse effects to the treatment. He was able to resume his normal daily routines the day after his treatment. A follow-up CT scan at 3, 8 and 12 months after treatment reported sufficient cryoablation and no sign of recurrence or other metastases. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer intervention; urological cancer

Mesh：

Year:  2019        PMID： 30904882      PMCID： PMC6453360          DOI： 10.1136/bcr-2018-227129

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  12 in total

1.  Efficacy of Cryoablation to Control Cancer Pain: A Systematic Review.

Authors:  Laura Ferrer-Mileo; Ana Isabel Luque Blanco; Jesús González-Barboteo
Journal:  Pain Pract       Date:  2018-06-07       Impact factor: 3.183

2.  Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation.

Authors:  Hyun J Bang; Peter J Littrup; Dylan J Goodrich; Brandt P Currier; Hussein D Aoun; Lance K Heilbrun; Ulka Vaishampayan; Barbara Adam; Allen C Goodman
Journal:  J Vasc Interv Radiol       Date:  2012-04-25       Impact factor: 3.464

3.  Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift?

Authors:  Hussein D Aoun; Peter J Littrup; Mohamed Jaber; Fatima Memon; Barbara Adam; Mark Krycia; Matthew Prus; Elisabeth Heath; Edson Pontes
Journal:  J Vasc Interv Radiol       Date:  2017-08-26       Impact factor: 3.464

4.  Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.

Authors:  Simon P Kim; Christopher J Weight; Bradley C Leibovich; R Houston Thompson; Brian A Costello; John C Cheville; Christine M Lohse; Stephen A Boorjian
Journal:  Urology       Date:  2011-09-08       Impact factor: 2.649

5.  Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients.

Authors:  David J Breen; Timothy J Bryant; Ausami Abbas; Beth Shepherd; Neil McGill; Jane A Anderson; Richard C Lockyer; Matthew C Hayes; Steve L George
Journal:  BJU Int       Date:  2013-04-12       Impact factor: 5.588

6.  Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).

Authors:  Sabine Brookman-May; Matthias May; Shahrokh F Shariat; Evanguelos Xylinas; Christian Stief; Richard Zigeuner; Thomas Chromecki; Maximilian Burger; Wolf F Wieland; Luca Cindolo; Luigi Schips; Ottavio De Cobelli; Bernardo Rocco; Cosimo De Nunzio; Bogdan Feciche; Michael Truss; Christian Gilfrich; Sascha Pahernik; Markus Hohenfellner; Stefan Zastrow; Manfred P Wirth; Giacomo Novara; Marco Carini; Andrea Minervini; Claudio Simeone; Alessandro Antonelli; Vincenzo Mirone; Nicola Longo; Alchiede Simonato; Giorgio Carmignani; Vincenzo Ficarra
Journal:  Eur Urol       Date:  2012-06-22       Impact factor: 20.096

7.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

8.  Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.

Authors:  R Houston Thompson; Tom Atwell; Grant Schmit; Christine M Lohse; A Nicholas Kurup; Adam Weisbrod; Sarah P Psutka; Suzanne B Stewart; Matthew R Callstrom; John C Cheville; Stephen A Boorjian; Bradley C Leibovich
Journal:  Eur Urol       Date:  2014-08-06       Impact factor: 20.096

9.  Soft-tissue cryoablation in diffuse locations: feasibility and intermediate term outcomes.

Authors:  Peter J Littrup; Hyun J Bang; Brandt P Currier; Dylan J Goodrich; Hussein D Aoun; Lance K Heilbrun; Barbara A Adam
Journal:  J Vasc Interv Radiol       Date:  2013-09-20       Impact factor: 3.464

Review 10.  Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients.

Authors:  J Ricardo Rivero; Jose De La Cerda; Hanzhang Wang; Michael A Liss; Ann M Farrell; Ronald Rodriguez; Rajeev Suri; Dharam Kaushik
Journal:  J Vasc Interv Radiol       Date:  2018-01       Impact factor: 3.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.